Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Rousselot

Showing results (31-40 of 195) with videos related to

Pageof 20
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Imatinib sensitizes T-cell lymphocytes from chronic myeloid leukemia patients to FasL-induced cell death: a brief communicationLaurence Legros, Nathalie Ebran, Emmanuelle Stebe, et al.
Blood|January 6, 2005
Farnesyltransferase inhibitor tipifarnib (R115777) preferentially inhibits in vitro autonomous erythropoiesis of polycythemia vera patient cellsJérôme Larghero, Nathalie Gervais, Bruno Cassinat, et al.
Journal of Hematology & Oncology|December 28, 2018
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel reviewJorge E Cortes, Jane F Apperley, Daniel J DeAngelo, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2003
Acute monocytic leukemia presenting as acute respiratory failureElie Azoulay, Fabienne Fieux, Delphine Moreau, et al.
The International Journal of Biological Markers|May 1, 2009
Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemiaSamia Mourah, Raphael Porcher, Géraldine Lescaille, et al.
Leukemia & Lymphoma|June 12, 2019
Common clonal origin of an EBV-positive diffuse large B cell lymphoma and a chronic myelomonocytic leukemiaLoïc Vasseur, Diane Lara, Emmanuelle Clappier, et al.
Journal of Leukocyte Biology|February 8, 2006
Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activationNicolas Boissel, Philippe Rousselot, Emmanuel Raffoux, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2007
Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case seriesAnne Bergeron, Delphine Réa, Vincent Levy, et al.
Leukemia Research|December 2, 2011
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemiaEmna Abdelhamid, Claude Preudhomme, Nathalie Helevaut, et al.
Infection Control and Hospital Epidemiology|June 25, 2016
The Plasmair Decontamination System Is Protective Against Invasive Aspergillosis in Neutropenic PatientsMarie-Paule Fernandez-Gerlinger, Anne-Sophie Jannot, Sophie Rigaudeau, et al.
Pageof 20

Showing results (31-40 of 195) with videos related to

Sort By:
Pageof 20
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Imatinib sensitizes T-cell lymphocytes from chronic myeloid leukemia patients to FasL-induced cell death: a brief communicationLaurence Legros, Nathalie Ebran, Emmanuelle Stebe, et al.
Blood|January 6, 2005
Farnesyltransferase inhibitor tipifarnib (R115777) preferentially inhibits in vitro autonomous erythropoiesis of polycythemia vera patient cellsJérôme Larghero, Nathalie Gervais, Bruno Cassinat, et al.
Journal of Hematology & Oncology|December 28, 2018
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel reviewJorge E Cortes, Jane F Apperley, Daniel J DeAngelo, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2003
Acute monocytic leukemia presenting as acute respiratory failureElie Azoulay, Fabienne Fieux, Delphine Moreau, et al.
The International Journal of Biological Markers|May 1, 2009
Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemiaSamia Mourah, Raphael Porcher, Géraldine Lescaille, et al.
Leukemia & Lymphoma|June 12, 2019
Common clonal origin of an EBV-positive diffuse large B cell lymphoma and a chronic myelomonocytic leukemiaLoïc Vasseur, Diane Lara, Emmanuelle Clappier, et al.
Journal of Leukocyte Biology|February 8, 2006
Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activationNicolas Boissel, Philippe Rousselot, Emmanuel Raffoux, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2007
Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case seriesAnne Bergeron, Delphine Réa, Vincent Levy, et al.
Leukemia Research|December 2, 2011
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemiaEmna Abdelhamid, Claude Preudhomme, Nathalie Helevaut, et al.
Infection Control and Hospital Epidemiology|June 25, 2016
The Plasmair Decontamination System Is Protective Against Invasive Aspergillosis in Neutropenic PatientsMarie-Paule Fernandez-Gerlinger, Anne-Sophie Jannot, Sophie Rigaudeau, et al.
Pageof 20